Short description
Plus Therapeutics is a clinical-stage pharmaceutical company that develops targeted therapies to treat cancer and other serious diseases.
Description
Plus Therapeutics is dedicated to developing and delivering innovative cell-based therapies to improve the quality and length of life. It is a global, public company engaged in developing and commercializing stem and regenerative cell therapies for treating cardiovascular disease, reconstructive surgery, and other serious, chronic, and life-threatening conditions. The company's research and development efforts are developing novel formulations and delivery methods for existing drugs to improve their efficacy and reduce side effects.
Plus Therapeutics utilizes its proprietary nanotechnology platform to enhance the therapeutic potential of drugs, allowing for targeted delivery to tumors while minimizing damage to healthy tissues. Their pipeline includes potential treatments for various types of cancer, including brain cancer and pancreatic cancer.
Plus Therapeutics' pipeline of candidate drug products includes their lead drug product candidates, RNL and DocePLUS, which are being developed in the U.S. by a dedicated and energetic team of biologists, chemists, engineers, physicians, and other professionals.
Last funding
Uh Ohhhh
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Austin, Texas, United States, North America
Founded on
January 1, 1996
Exited on
December 30, 2004
Went public on
December 30, 2004
Stock symbol
PSTV
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$1230 - 4560
Sign in for full access
Investors
Uh Ohhhh, Noaccess, Uh Ohhhh, Noway Youcantaccess, Nopepepe, Nopepepe
Sign in for full access
Founders
Christopher Calhoun, Ralph Holmes